Neuroactive steroids are synthesized de novo in brain, yet their physiological significance remains elusive. We provide biochemical, electrophysiological, and behavioral evidence that several specific actions of alcohol (ethanol) are mediated by the neurosteroid 3␣-hydroxy-5␣-pregnan-20-one (3␣,5␣-THP; allopregnanolone). Systemic alcohol administration elevates 3␣,5␣-THP levels in the cerebral cortex to pharmacologically relevant concentrations. The elevation of 3␣,5␣-THP is doseand time-dependent. Furthermore, there is a significant correlation between 3␣,5␣-THP levels in cerebral cortex and the hypnotic effect of ethanol. Blockade of de novo biosynthesis of 5␣-reduced steroids using the 5␣-reductase inhibitor finasteride prevents several effects of ethanol. Pretreatment with finasteride causes no changes in baseline bicuculline-induced seizure threshold but reverses the anticonvulsant effect of ethanol. Finasteride pretreatment also reverses ethanol inhibition of spontaneous neural activity in medial septal/diagonal band of Broca neurons while having no direct effect on spontaneous firing rates. Thus, elevation of 3␣,5␣-THP levels by acute ethanol administration represents a novel mechanism of ethanol action as well as an important modulatory role for neurosteroids in the CNS.
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Steroid hormones have long been recognized as endocrine signals regulating essential functions such as metabolism, catabolism, and reproduction. Classically, steroids are recognized for their genomic action as transcriptional regulators, however they have been more recently characterized in a nongenomic role of direct interaction with membrane-bound receptors (for review, see Rupprecht and Holsboer, 1999) . Recent research has indicated that certain of these steroids can be synthesized in brain without peripheral precursors and have nongenomic effects that produce both excitatory and inhibitory actions at various receptor classes in brain (Paul and Purdy, 1992; Robel and Baulieu, 1995) . 3␣,5␣-THP is an endogenous pregnane steroid and potent agonist modulator of the inhibitory neurotransmitter GABA A receptor subtype. 3␣,5␣-THP is increased in brain in many stress paradigms (Purdy et al., 1991; Barbaccia et al., 1996; Barbaccia et al., 1997) , as well as during naturally occurring hormonal fluctuations such as the estrus cycle (Ichikawa et al., 1974; Paul and Purdy, 1992; Finn and Gee, 1993) and pregnancy (Concas et al., 1998) . A wealth of evidence demonstrates that the anxiolytic, sedative/ hypnotic, and anticonvulsant effects attributed to 3␣,5␣-THP are mediated by enhancement of chloride ion conductance through GABA A receptors in brain (Morrow, 1995) .
Behavioral and neurochemical evidence suggests that alcohol exerts pharmacological effects remarkably similar to GABA A receptor modulators, including 3␣,5␣-THP (Suzdak et al., 1986b; Grobin et al., 1998) . Several ethanol effects are enhanced by the positive GABA A receptor modulators benzodiazepines and barbiturates, but are blocked by GABA A receptor antagonists and inverse agonists (Suzdak et al., 1986a; Nutt and Lister, 1989; Givens and Breese, 1990; Liu and Deitrich, 1998) . For example, sedative/hypnotic effects produced by high doses of ethanol are mediated by GABA A receptors and can be enhanced by GABA agonists and blocked by GABA receptor antagonists (Martz et al., 1983) . However, the conclusion that ethanol has direct effects on GABA A receptors is controversial. Although ethanol potentiation of GABA A receptor-mediated responses are observed in Cl Ϫ flux studies, there is a lack of consistent electrophysiological evidence that ethanol interacts directly with GABA A receptors in vivo and in vitro. For example, ethanol increases GABA-mediated inhibition in some brain regions, but not others (Givens and Breese, 1990; Simson et al., 1991) . Whole-cell patch-clamp recording techniques have also provided mixed results concerning the ability of ethanol to enhance GABA inhibition (Mancillas et al., 1986; Frye et al., 1994; Marszalec et al., 1998; Sapp and Yeh, 1998) .
Because ethanol is known to have effects on the GABA A receptor, and 3␣,5␣-THP is such a potent modulator of the same receptor, we became interested in a possible interaction between these two agents. Ethanol activates the hypothalamic-pituitary axis and has been shown to cause increases in plasma levels of several steroids, including corticosterone, testosterone, and progesterone (Rivier et al., 1984; Korneyev et al., 1993b; Schuckit and Smith, 1996) . In this study, we investigated whether ethanol alters brain levels of the GABAergic neurosteroid 3␣,5␣-THP and if steroid biosynthetic enzyme inhibitors prevent this effect. We also investigated the effect of blockade of steroid biosynthesis on anticonvulsant and electrophysiological effects of ethanol, as well as the temporal relationship between 3␣,5␣-THP elevation and these effects of ethanol. Our results suggest that 3␣,5␣-THP plays a modulatory role in ethanol action at the GABA A receptor and contributes to certain electrophysiological and behavioral effects in vivo.
MATERIALS AND METHODS
All experiments were conducted in accordance with National Institutes of Health Guidelines under Institution Animal C are and Use Committee-approved protocols. Male Sprague Dawley rats (200 -240 gm) were purchased from Harlan (Indianapolis, I N) and were group-housed in controlled conditions (lights on, 6:00 A.M. to 6:00 P.M.) with ad libitum access to rat chow and water. All animals were handled and habituated to vehicle injections for 5 d before experiments. All experiments were performed at the beginning of the light cycle to minimize diurnal steroid fluctuations. Radioimmunoassays. RIAs were performed as described previously (Janis et al., 1998) . Steroids were extracted from individual cerebral cortical hemispheres that were rapidly dissected in ice-cold saline after euthanasia. Cortices were then frozen at Ϫ80°C until use. Recovery was monitored by the incorporation of 4000 dpm of [ 3 H]3␣,5␣-THP. Samples were digested in 0.3 N NaOH by a sonic dismembrator and extracted three times in 3 ml aliquots of 10% (v/ v) ethyl acetate in heptane. The aliquots were combined and diluted with 4 ml of heptane. The extracts were applied to solid phase silica columns (Burdick & Jackson, Muskegon, M I), washed with pentane, and steroids of similar polarity to 3␣,5␣-THP were eluted off of the column by the addition of 25% (v/ v) acetone in pentane. The eluant was then dried under N 2 and steroids were redissolved in 20% (v/ v) isopropanol RIA buffer (0.1 M NaH 2 PO 4 , 0.9 M NaC l, 0.1% w/ v BSA, pH 7.0). E xtraction efficiency was determined in 50 l of the redissolved extract by liquid scintillation spectroscopy. E xtraction efficiency ranged between 95 and 100%. The remaining 200 l was used in the determination of 3␣,5␣-THP by radioimmunoassay.
Reconstituted sample extracts (75 l) and 3␣,5␣-THP standards (5-40,000 pg in 6.25% v/ v ethanol, 31% v/ v isopropyl alcohol in RIA buffer) were assayed in duplicate by the addition of 725 l of RIA buffer, 100 l of [ 3 H]3␣,5␣-THP (20,000 dpm), and 100 l of anti-3␣,5␣-THP antibody (1:500; gift of CoC ensys, Irvine, CA). Total binding was determined in the absence of unlabeled 3␣,5␣-THP, and nonspecific binding was determined in the absence of antibody. The antibody-binding reaction was allowed to equilibrate for 120 min at room temperature and was terminated by cooling the mixture to 4°C. Bound 3␣,5␣-THP was separated from unbound 3␣,5␣-THP by incubation with 300 l of cold dextrancoated charcoal (DCC; 0.04% dextran, 0.4% powdered charcoal in double-distilled H 2 O) for 20 min. DCC was removed by centrif ugation at 2000 ϫ g for 10 min. Bound radioactivity in the supernatant was determined by liquid scintillation spectroscopy. Sample values were compared to a concurrently run 3␣,5␣-THP standard curve (0, 0.005, 0.01, 0.02, 0.04, 0.08, 0.16, 0.31, 0.62, 1.25, 2.5, 5.0, 10.0, 20.0, and 40 .0 ng /tube) produced using a one-site competition model (Prism2; GraphPad, San Diego, CA). Sample values were adjusted to account for the previously determined extraction efficiency. The sensitivity of the assay was 15-20 pg /tube, and the interassay coefficient of variation was 9.1%.
Administration of biosynthesis inhibitors. Finasteride (Sigma, St. L ouis, MO), a 5␣-reductase inhibitor, was administered 4 and 1.5 hr before ethanol injection. It was administered subcutaneously in a 2 ml/kg suspension of finasteride in 20% (w/ v) 2-hydroxypropyl-␤-cyclodextrin (HCD) (Research Biochemicals, Natick, M A) at either a 25 or 50 mg / kg dose. Doses of finasteride were determined by review of finasteride use in previous behavioral and biochemical experiments in rodents (Lephart et al., 1996; Concas et al., 1998; Kokate et al., 1999) . Finasteride (50 mg / kg, s.c.) alters open field behavior in pregnant females rats and decreased enzyme activity by 60 -80% (Lephart et al., 1996) .
Indomethacin (IC N Biomedicals, Aurora, OH), a 3␣-HSD inhibitor, was administered 20 min before ethanol injection. Indomethacin was administered in a 1 ml / kg solution of 20% HCD, intraperitoneally, at a dose of 0.1 mg / kg. This dose has been reported to block 3␣,5␣-THP formation in a pseudopregnant rat model (Smith et al., 1998a) . Trilostane (Sanofi, Malvern, PA), a 3␤-HSD inhibitor, was administered 2 hr before ethanol injection. Trilostane was administered in a 2 ml / kg solution of 20% HCD, intraperitoneally at a dose of 30 mg / kg. This dose has been reported to significantly decrease conversion of pregnenolone to progesterone (Potts et al., 1978; Korneyev et al., 1993b) .
Loss of righting refle x . Ethanol-induced sleep time was determined by the duration of the loss of righting reflex, defined as the inability to right three times in 1 min after placement in the supine position. Ethanol (3.5 gm / kg; 20% v/ v in saline) was administered by intraperitoneal injection; rats were replaced in their cage until righting reflex was lost and then placed in a V-shaped support in the supine position until recovery. Rats were administered finasteride (25 or 50 mg / kg) or vehicle [20% (w/ v) 2-hydroxypropyl-␤-cyclodextrin; Research Biochemicals] subcutaneously, 4 and 1.5 hr before ethanol administration.
Seizure thresholds. Rats were administered finasteride (25 or 50 mg / kg) or vehicle [20% (w/ v) 2-hydroxypropyl-␤-cyclodextrin] subcutaneously, 4 and 1.5 hr before intraperitoneal ethanol administration. Seizure threshold was measured either 10 or 40 min after ethanol (2.0 gm / kg) administration. Rats were gently restrained for insertion of a 25 ga butterfly needle into the lateral tail vein, then held lightly by the tip of the tail while allowed free movement. Bicuculline (0.05 mg /ml) was inf used at a rate of 1.6 ml /min until the first myoclonic twitch of the face and /or neck. Seizure threshold (milligrams per kilogram) was calculated as the duration of inf usion ϫ dose of bicuculline/ body weight.
Single-cell electrophysiolog ical recordings. Rats were anesthetized with urethane (1.5 gm / kg) and placed in a stereotaxic frame. An incision was made in the skin, the skull surface was cleaned, and a burr hole was drilled through the skull 0.3 mm anterior and 1.5 mm lateral of bregma. Single-barrel glass micropipettes were pulled (using Model PE-2; Narishige, Tokyo, Japan) and the tip was broken back to ϳ1.0 m and filled with a 0.9 M NaC l solution saturated with Chicago sky-blue dye. The electrode was lowered into the medial septum /diagonal band of Broca (MS/ DB) via a hydraulic microdrive (Trent Wells, South Gate, CA). E xtracellular action potentials were amplified, filtered (300 Hz and 8 kHz; Fintronics, Orange, C T), and were monitored with a Tektronix oscilloscope and audiomonitor. Individual action potentials isolated from background activity with at least 3:1 signal-to-noise ratios, constant duration /configuration, and rhythmically bursting patterns were defined as single MS/ DB neurons using previously published criteria (Givens and Breese, 1990) . Individual action potentials were digitized by a window discriminator (Fintronics), and the pulse was fed into an I BM personal computer that generated 10 sec time bin ratemeter histograms.
After isolation of a single MS/ DB neuron, at least a 5 min baseline of spontaneous neural activity was collected, after which rats received a 1.5 gm / kg ethanol (10% w/ v) intraperitoneal injection; thereafter, an additional 60 min of spontaneous activity was recorded. C are was taken to monitor the waveform of the action potential, and the electrode location was micromanipulated to prevent waveform alterations. After completion of the recording, a current was passed through the electrode, thereby depositing dye and marking its location. The brain was then removed from the animal, frozen, and sliced to verif y electrode location. All neurons analyzed were located in the MS/ DB (data not shown).
Statistics. Statistical analysis was done with Statview (Abacus Concepts, Berkeley, CA) and GraphPad Prism (GraphPad Software).
RESULTS

Ethanol induction of 3␣,5␣-THP in cerebral cortex
Levels of 3␣,5␣-THP in cerebral cortex were dramatically increased 60 min after acute ethanol administration (1.3-4.0 gm/ kg, i.p.; 20% v/v in saline) to male Sprague Dawley rats (Fig. 1 A) . Changes in cerebral cortical levels of 3␣,5␣-THP induced by ethanol were dose-dependent (Fig. 1 A) . There was a smaller 3␣,5␣-THP response at 4.0 gm/kg ethanol, but all doses measured beyond 1 gm/kg were significantly elevated above saline controls (one-way ANOVA, F ϭ 13.20, p Ͻ 0.0001; Dunnett's post hoc, p Ͻ 0.05). Doses of ethanol from 2-3 g/kg caused increases in 3␣,5␣-THP levels in cortex from 2.7 ng/gm to 10 -12 ng/gm.
The effect of ethanol (2 gm/kg, i.p.) was observed 20 min after ethanol injection and peaked between 40 and 80 min (Fig. 1 B) .
3␣,5␣-THP levels in cerebral cortex of saline-injected rats were only mildly elevated at 20 min after injection and returned to baseline conditions by 40 min (Fig. 1 B) . Hence, the stress associated with injection did not significantly contribute to cerebral cortical levels of 3␣,5␣-THP in ethanol-treated rats. Plasma levels of progesterone and corticosterone were positively correlated after ethanol administration (r ϭ 0.829; p Ͻ 0.0001); however, these levels did not correlate with ethanol-induced increases in cerebral cortical 3␣,5␣-THP levels (r ϭ 0, p ϭ 0.964; r ϭ 0.179, p ϭ 0.371, respectively; see Table 2 ). Moreover, cerebral cortical 3␣,5␣-THP levels did not correlate with plasma 3␣,5␣-THP levels measured between 0 and 120 min (r ϭ 0.269, p ϭ 0.074; see Table 2 ).
Ethanol-induced elevations of 3␣,5␣-THP levels could occur via several mechanisms, including modulation of de novo biosynthesis, catabolism, or endogenous steroid release. To determine if 3␣,5␣-THP levels are increased after ethanol exposure as a result of de novo biosynthesis, the effects of steroid biosynthesis inhibitors were investigated. Three of these inhibitors were used, the 3␤-hydroy x steroidox idoreductase/i somerase inhibitor trilostane, the 5␣-reductase inhibitor finasteride, and the 3␣-hydroxysteroidoxidoreductase inhibitor indomethacin (Potts et al., 1978; Penning et al., 1985; Steiner, 1996) . The irreversible steroid 5␣-reductase type II inhibitor finasteride was the only inhibitor that reduced the effect of ethanol on cerebral cortical 3␣,5␣-THP and plasma corticosterone levels ( Table 1) . As previously reported, indomethacin paradoxically increased 3␣,5␣-THP levels over those of ethanol-induced 3␣,5␣-THP in cortex , while still decreasing corticosterone levels (Table 2) . Trilostane reduced plasma progesterone levels, but had no effect on ethanol-induced changes in cortical 3␣,5␣-THP or plasma corticosterone.
3␣,5␣-THP modulation of ethanol-mediated behaviors
Having established that acute ethanol administration increases cerebral cortical 3␣,5␣-THP levels, we investigated the hypothesis that 3␣,5␣-THP contributes to the behavioral effects of ethanol. Because the sedative-hypnotic effects of ethanol involve the activation of GABA A receptors, we investigated whether ethanolinduced 3␣,5␣-THP levels in the cerebral cortex were correlated with the hypnotic effect of ethanol. Male Sprague Dawley rats were injected with 3.5 gm/kg ethanol [20% (w/v) in saline], and sleep time was measured from loss of righting reflex until righting reflex recovered. Cerebral cortical 3␣,5␣-THP levels were clearly correlated (r ϭ 0.59; p Ͻ 0.0001) with ethanol-induced sleep time (Fig. 2) .
Acute ethanol administration has been shown to increase bicuculline-induced seizure threshold in rats (Rastogi et al., 1986; Glowa et al., 1988; Nutt and Lister, 1989) . Ethanol administration (2 gm/kg) increased bicuculline seizure threshold 40 min, but not 10 min after ethanol administration (two-way ANOVA, effect of drug, p Ͻ 0.02; Tukey's multiple comparison, *p Ͻ 0.02) (Fig.  3A) . This time course of anticonvulsant action correlates with the time course of ethanol induction of cerebral cortical 3␣,5␣-THP levels (Fig. 1 B) . Pretreatment with finasteride (50 mg/kg, s.c.) under the same experimental conditions completely prevented Figure 1 . Cerebral cortical 3␣,5␣-THP levels are elevated after acute, systemic ethanol administration. A, Cerebral cortical 3␣,5␣-THP levels exhibit a biphasic response to increasing ethanol concentrations. Ethanol increased 3␣,5␣-THP levels to pharmacologically active concentrations at doses between 1.35 and 4.0 gm/kg (*p Ͻ 0.0001, ANOVA; p Ͻ 0.05, Dunnett's post hoc) measured 60 min after ethanol administration. Data represent mean Ϯ SEM of duplicate determinations in 6 -10 rats per dose from two independent experiments. Further analysis of trend shows a significant match to a quadratic equation (F (1,32) ϭ 17.49; p Ͻ 0.05) using random samples of five rats per dose. B, Cerebral cortical 3␣,5␣-THP levels peak between 40 and 80 min after an injection of ethanol (2 gm/kg, i.p.) followed by a gradual decrease. Data shown are the mean Ϯ SEM of a representative experiment repeated twice with similar results (n ϭ 6/time point; *p Ͻ 0.05 Dunnett's post hoc). (Fig. 3B ).
3␣,5␣-THP modulates electrophysiological actions of ethanol
The ability of finasteride to modulate ethanol-induced effects on neural activity in the brain was investigated by monitoring spontaneous firing rates of MS/DB neurons. MS/DB cells show a high rate of spontaneous firing (Givens and Breese, 1990 ) that was inhibited by a maximum of 38.0 Ϯ 1.52%, 20 -40 min after systemic injection (Fig. 4 A) . Although maximal inhibition was between 20 and 40 min, spontaneous firing was inhibited from baseline throughout the recording period. Previous work has shown that complete recovery is not attained until 90 min (Givens and Breese, 1990) . Finasteride pretreatment reversed the inhibition of spontaneously active MS/DB neurons produced by systemic ethanol administration ( p Ͻ 0.0001, two-way ANOVA with repeated measures; main effect of finasteride, F (2,152) ϭ 34.77; Baseline spontaneous neural activity was not altered by finasteride pretreatment (one-way ANOVA; F (2,13) ϭ 2.13; p Ͼ 0.05; Fig. 4 B) . Baseline firing rates for the ethanol only group ranged from 12.5-59.1 Hz, the ethanol ϩ 25 mg/kg finasteride group ranged from 14.2-31.6 Hz, and the ethanol ϩ 50 mg/kg finasteride group ranged from 10.9 -23.3 Hz. Moreover, the time course of the onset of ethanol inhibition of spontaneous neural activity in the MS/DB is very similar to the time course of ethanol-induced 3␣,5␣-THP elevation in cerebral cortex. However, the time course of the recovery of MS/DB spontaneous neural activity precedes the time course of return to baseline 3␣,5␣-THP levels in cortex.
DISCUSSION
These data reveal an important interaction between ethanol and the endogenous pregnane neurosteroid 3␣,5␣-THP. Ethanol induces a dose-and time-dependent increase in cerebral cortical 3␣,5␣-THP levels to physiologically relevant concentrations. The time course of the induction of this potent GABA modulator at a moderate ethanol dose correlates with the appearance of specific behavioral and electrophysiological effects of ethanol. These effects are reversed when 3␣,5␣-THP induction is reduced by finasteride, indicating that 3␣,5␣-THP mediates or modulates some GABAergic effects of ethanol. Ethanol induces an increase in cortical 3␣,5␣-THP levels sufficient to potentiate GABA A receptor-mediated inhibition in brain (Harrison et al., 1987; Morrow et al., 1987) . The maximal induction of cortical 3␣,5␣-THP by ethanol is greater than the induction of 3␣,5␣-THP triggered by various stressors (Purdy et al., 1991; Barbaccia et al., 1996) . It is interesting to note that moderate doses of ethanol induced the largest 3␣,5␣-THP responses at the 60 min time point. This could be reflective of a Figure 2 . Elevations in cerebral cortical 3␣,5␣-THP are related to the hypnotic effect of ethanol. Alcohol (3.5 gm/kg, i.p.) was administered to male rats. The duration of the loss of righting reflex (sleep time) was correlated (r ϭ 0.59; p Ͻ 0.0001; n ϭ 37) with cerebral cortical 3␣,5␣-THP levels measured after awakening. varying time course in the elevation of 3␣,5␣-THP levels. Alternatively, this may indicate ethanol effects on 3␣,5␣-THP biosynthetic enzyme kinetics or desensitization to ethanol. Similar biphasic effects of ethanol and barbiturates on GABA A receptormediated Cl Ϫ flux (Schwartz et al., 1986) have previously been observed.
The observation that brain 3␣,5␣-THP levels do not correlate with plasma corticosterone (a peripheral indicator of HPA axis activity), progesterone (a precursor of 3␣,5␣-THP), or plasma 3␣,5␣-THP itself suggests that brain steroid levels may be differentially regulated from circulating steroids. The absence of a correlation between central and circulating 3␣,5␣-THP levels could be attributable to different time courses for steroid production or metabolism between the periphery and brain. Although it is premature to conclude that brain levels are independent of peripheral steroid sources, evidence suggests that neurosteroid biosynthesis in brain may include novel nonenzymatic pathways (Lieberman and Prasad, 1990; Prasad et al., 1994; Cascio et al., 1998) .
The corroboration of single-cell recording data demonstrates the specific physiological role of ethanol-induced 3␣,5␣-THP in vivo. Ethanol suppression of MS/DB spontaneous activity is temporally correlated with the increase in cortical levels of 3␣,5␣-THP and reversed by finasteride pretreatment, demonstrating that 3␣,5␣-THP contributes to this response. The time course of the effects of ethanol on spontaneous activity and 3␣,5␣-THP levels are very similar, despite differences in the brain regions and the dose of ethanol. Furthermore, single-cell recordings of the neighboring lateral septum, a brain region in which ethanol does not alter the spontaneous firing rate of neurons, show no effect of either ethanol or finasteride (data not shown). The enzymes responsible for 3␣,5␣-THP production in the brain are regionally expressed (Roselli and Snipes, 1984; Korneyev et al., 1993a; Martini et al., 1996) , highlighting the possible importance of studying the regional modulation of these compounds by ethanol.
The correlation of ethanol-induced loss of righting reflex and brain 3␣,5␣-THP levels suggests that 3␣,5␣-THP contributes to the hypnotic effect of ethanol, likely via GABA A receptor activation. The ability of finasteride to block the anticonvulsant effect of ethanol on bicuculline seizure thresholds further substantiates the role of 3␣,5␣-THP in ethanol-induced behavior. The effects of finasteride on ethanol action provide significant evidence that neurosteroid intermediaries contribute to ethanol action; however, because these steroids share many of the same biosynthetic enzymes, the possible involvement of other 5␣-reduced steroids cannot be ruled out.
In fact, it is known that ethanol increases plasma levels of several steroids, including corticosterone, testosterone, and progesterone (Rivier et al., 1984; Korneyev et al., 1993b; Schuckit and Smith, 1996) . Further research is needed to determine if similar effects are found with other GABAergic neurosteroids such as 3␣,21-dihydroxy-5␣-pregnan-20-one or 3␣-hydroxy-5␤-pregnane-20-one. Recent studies suggest that 3␣,5␣-THP also modulates other ion channels, including the nicotinic acetylcholine receptor and the serotonin 5-HT 3 receptor, but these effects require much greater concentrations (10 M) than observed in response to ethanol (1-4 gm/kg) (Rupprecht and Holsboer, 1999) .
The fact that finasteride inhibits some of the GABAergic effects of ethanol suggests that ethanol may alter the biosynthesis of 3␣,5␣-THP. Because finasteride is selective for 5␣-reductase type 2 activity in vivo (Bramson et al., 1997) , inhibition of type 1 enzyme activity may be required to obtain complete inhibition of ethanol effects. However, it appeared that the activity of steroid biosynthesis inhibitors was altered in the presence of ethanol, compared to previously published reports (Korneyev et al., 1993b; Costa et al., 1995; Smith et al., 1998b; Griffin and Mellon, 1999) . For example, trilostane significantly decreased plasma progesterone levels, but did not change cortical 3␣,5␣-THP levels. This is surprising because previous reports suggest that this dose blocks formation of 3␣,5␣-THP (Concas et al., 1998) . This raises the possibility that ethanol increases the activity of the 3␣-HSD enzyme, as recently suggested by Griffin and Mellon (1999) in their study of 3␣-HSD kinetics. Further studies are needed to distinguish if ethanol has direct effects on the neurosteroid biosynthetic enzymes or the efficacy of the enzyme inhibitors.
Alternatively, the lack of effect of biosynthesis inhibitors on ethanol-induced 3␣,5␣-THP levels may indicate that the elevation in 3␣,5␣-THP is independent of de novo biosynthesis of 3␣,5␣-THP. This could occur if ethanol stimulates the release of 3␣,5␣-THP from stores in adrenals or glial cells. Finasteride pretreatment may have depleted stores of 3␣,5␣-THP, because it was administered 4 and 1.5 hr before ethanol, and thereby partially inhibited the effects of ethanol. Further studies are required to investigate this possibility.
Despite the observation that finasteride had a partial effect on cortical 3␣,5␣-THP levels, it is not surprising that finasteride did not have an effect on baseline seizure threshold and electrophysiological measurements. Endogenous levels of 3␣,5␣-THP in naïve male rats are very low, certainly below physiologically relevant concentrations (Purdy et al., 1991) . Furthermore, the dose of finasteride used (50 mg/kg) is below the EC 50 for blockade of the anticonvulsant effects of progesterone in mice (Kokate et al., 1999) .
Previous studies demonstrated that brain 3␣,5␣-THP levels are elevated by the specific serotonin reuptake inhibitors (SSRIs) fluoxetine and paroxetine (Uzunov et al., 1996; Uzunova et al., 1998) . Because elevations in endogenous 3␣,5␣-THP levels enhance the hypnotic effects of pentobarbital (Matsumoto et al., 1999) , elevations in 3␣,5␣-THP may also contribute to hypnotic properties of SSRIs or ethanol. The overlapping effects of ethanol and SSRIs, such as anxiolytic, sedative, and stress-reducing properties, may relate to the ability of these drugs to elevate 3␣,5␣- Figure 4 . Finasteride pretreatment prevents ethanol-induced inhibition of spontaneous neural activity in MS/DB neurons. A, Systemic ethanol injection (1.5 gm/kg, i.p.) reduced spontaneous neural activity by a maximum of 38.00 Ϯ 1.52%, 20 -40 min after injection. Finasteride pretreatment reversed the inhibition of spontaneously active MS/DB neurons produced by systemic ethanol administration ( p Ͻ 0.0001, two-way ANOVA with repeated measures; main effect of finasteride, F (2,152) ϭ 34.77). Complete blockade of ethanol inhibition was observed between 16 and 25 min after the ethanol injection at both doses of finasteride. However, only the high dose of finasteride completely blocked ethanol inhibition throughout the recording session. Inset is a representative oscilloscope trace of medial septum/diagonal band of Broca neuron. B, Baseline firing rate (5 min before ethanol); *p Ͻ 0.05; †p Ͻ 0.07. B, A grand mean of ethanol-induced inhibition for each neuron was calculated by collapsing the data across the 12, 5 min time bins. Acute ethanol administration inhibited the spontaneous activity of MS/DB neurons compared to preinjection baseline (paired t test, T ϭ 3.12; *p Ͻ 0.05). Pretreatment with 25 mg/kg finasteride did not alter the effect of ethanol on spontaneous firing rate. However, pretreatment with 50 mg/kg finasteride completely prevented ethanol-induced inhibition of spontaneous MS/DB neural activity (one-way ANOVA, F (2,13) ϭ 5.45, p Ͻ 0.02; Tukey's post hoc test, q ϭ 4.593, †p Ͻ 0.05). C, Representative MS/DB neural traces from an animal treated with ethanol only and an animal treated with ethanol ϩ 50 mg/kg finasteride. Each neuron was recorded for 60 min after a 1.5 gm/kg ethanol injection (vertical arrow). The neural trace preceding the vertical arrow is the baseline recording session. Note, ethanol injection resulted in an ϳ32% inhibition in the MS/DB neuron from the control rat, whereas the ethanol-induced inhibition was completely blocked by pretreatment with 50 mg/kg finasteride.
THP levels in brain. However, alcohol and SSRIs each have other independent neurochemical actions that likely account for other diverse effects of these drugs. The modulation of 3␣,5␣-THP levels by SSRIs and ethanol further support the important role of 3␣,5␣-THP in the regulation of CNS function.
It is important to note that ethanol affects several ion channels (Crews et al., 1996) . Some effects of ethanol can be observed minutes after administration. The effects that we measured are observed at later time points. Anticonvulsant effects of ethanol and the depression of MS/DB spontaneous activity occur between 15 and 80 min after ethanol administration and correlate very well with maximal 3␣,5␣-THP elevation. Thus, our data speak directly to 3␣,5␣-THP modulation of these GABAergic functions and do not preclude direct ethanol activity at GABA A receptors or other ion channels.
Other investigators have demonstrated important roles for 3␣,5␣-THP in ethanol action. In a discriminative stimulus paradigm, Bowen et al. (1999) showed that GABAergic neurosteroids substitute for ethanol in both primates and rats. Exogenous administration of 3␣,5␣-THP altered ethanol reinforced operant responding (Janak et al., 1998) . Because neurosteroids are such potent modulators of the GABAergic pathways involved not only in alcohol action, but also in anxiety, seizure, and movement disorders, there are possible clinical ramifications of these data. A specific antagonist of GABAergic neurosteroid action may be useful in treating alcoholism because of the role we have shown for 3␣,5␣-THP in modulating ethanol actions as well as the roles for 3␣,5␣-THP in alcohol reinforcement, reward, and perhaps tolerance (Janak et al., 1998; Bowen et al., 1999) .
The identification of a neuroactive steroid as an intermediary of ethanol actions at GABA A receptors provides an important example of functional interactions between the genomic and nongenomic actions of neurosteroids. GABA A receptor function and mRNA expression are modulated by changes in neurosteroid levels during pregnancy, and this modulation can be reversed by finasteride (Concas et al., 1998) . In our studies, chronic ethanol administration reduced basal levels of 3␣,5␣-THP in cerebral cortices of male rats (Janis et al., 1998) . We have also found that ethanol-dependent rats are sensitized to the anticonvulsant effect of 3␣,5␣-THP during ethanol withdrawal (Devaud et al., 1996) . Moreover, chronic ethanol exposure and withdrawal (Devaud et al., 1995 (Devaud et al., , 1997 Matthews et al., 1998) have been shown to cause changes in GABA A receptor ␣4 subunit mRNA and peptide expression that mirror the effects of withdrawal from progesterone and 3␣,5␣-THP (Smith et al., 1998a) . Taken together, these data demonstrate that neuroactive steroids such as 3␣,5␣-THP can elicit synergistic actions involving both nongenomic and genomic effects on GABA A receptors that enable long-term adaptations in receptor function and expression.
